The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.
Parkinson’s disease dementia: a neural networks perspective
Open accessAbstract
In the long-term, with progression of the illness, Parkinson's disease dementia affects up to 90% of patients with Parkinson's disease. With increasing life expectancy in western countries, Parkinson's disease dementia is set to become even more prevalent in the future. However, current treatments only give modest symptomatic benefit at best. New treatments are slow in development because unlike the pathological processes underlying the motor deficits of Parkinson's disease, the neural mechanisms underlying the dementing process and its associated cognitive deficits are still poorly understood. Recent insights from neuroscience research have begun to unravel the heterogeneous involvement of several distinct neural networks underlying the cognitive deficits in Parkinson's disease dementia, and their modulation by both dopaminergic and non-dopaminergic transmitter systems in the brain. In this review we collate emerging evidence regarding these distinct brain networks to give a novel perspective on the pathological mechanisms underlying Parkinson's disease dementia, and discuss how this may offer new therapeutic opportunities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Neural Mechanisms of Selective Visual Attention
Desimone, R., & Duncan, J. (1995) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.18.030195.001205 · Cited by 8,388 · cited 1×
“It is automatic capture of attention and thought to be driven by ‘bottom-up’ signals from salient stimuli (Desimone and Duncan, 1995).”
The attention system of the human brain
Posner, M. I., & Petersen, S. E. (1990) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.13.030190.000325 · Cited by 8,070 · cited 1×
“Attention is a heterogeneous construct that has been considered to comprise three different subsystems: executive control, orienting and alerting (Posner and Petersen, 1990; Petersen and Posner, 2012).”
Saliency, switching, attention and control: a network model of insula function
Menon, V., & Uddin, L. Q. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0262-0 · Cited by 5,592
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Ungerleider, L. G. (1982) · Medical Entomology and Zoology · Cited by 4,531
Attention to Action: Willed and Automatic Control of Behavior
Norman, D. A., & Shallice, T. (1986) · Consciousness and Self-Regulation · doi:10.1007/978-1-4757-0629-1_1 · Cited by 4,455
(2007) · Cognitive Psychology · doi:10.4135/9781446212967.n15 · Cited by 3,749
The attention system of the human brain: 20 years after
Petersen, S. E., & Posner, M. I. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150525 · Cited by 3,439 · cited 2×
“The complex neural networks that mediate attention functions in the healthy state are subject to ongoing debate (Petersen and Posner, 2012).”
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21507 · Cited by 3,027
A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease
Deuschl, G., Schade-Brittinger, C., Krack, P., Volkmann, J., Schäfer, H., Bötzel, K., Daniels, C., Deutschländer, A., Dillmann, U., Eisner, W., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060281 · Cited by 2,944
Squire, L. R., Stark, C. E. L., & Clark, R. E. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144130 · Cited by 2,680
Top-Down Versus Bottom-Up Control of Attention in the Prefrontal and Posterior Parietal Cortices
Buschman, T. J., & Miller, E. K. (2007) · Science · doi:10.1126/science.1138071 · Cited by 2,380
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M., & Morris, J. G. L. (2008) · Movement Disorders · doi:10.1002/mds.21956 · Cited by 2,246
Fuster, J. M. (1997) · Cited by 2,244
Mechanisms of visual attention in the human cortex
Ungerleider, S. K. A. L. G. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.315 · Cited by 2,159
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Basal ganglia and cerebellar loops: motor and cognitive circuits
Middleton, F. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00040-5 · Cited by 1,940
Electrical Signs of Selective Attention in the Human Brain
Hillyard, S. A., Hink, R. F., Schwent, V. L., & Picton, T. W. (1973) · Science · doi:10.1126/science.182.4108.177 · Cited by 1,934
The role of phase synchronization in memory processes
Fell, J., & Axmacher, N. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2979 · Cited by 1,620
Battig, W. F., Tulving, E., & Donaldson, W. (1973) · The American Journal of Psychology · doi:10.2307/1421962 · Cited by 1,412
Consciousness and Self-Regulation: Advances in Research and Theory Volume 2
(1978) · Springer eBooks · doi:10.1007/978-1-4684-2571-0 · Cited by 1,362
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1×
“However, in stark contrast to the nigrostriatal pathology underlying the motor aspects of the disorder (Fahn et al. , 1971; Hirsch et al. , 1988), the pathophysiological mechanisms underlying PDD remain obscure, which hinders the development of new therapies.”
Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease
Hoops, S., Nazem, S., Siderowf, A. D., Duda, J. E., Xie, S. X., Stern, M. B., & Weintraub, D. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34b47 · Cited by 1,260
Rivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., De Deyn, P. P., Durif, F., Kulisevsky, J., van Laar, T., Lees, A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,223
Cortical Map Reorganization Enabled by Nucleus Basalis Activity
Kilgard, M. P., & Merzenich, M. M. (1998) · Science · doi:10.1126/science.279.5357.1714 · Cited by 1,195
Dubois, B., Burn, D., Goetz, C., Aarsland, D., Brown, R. G., Broe, G. A., Dickson, D., Duyckaerts, C., Cummings, J., Gauthier, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21844 · Cited by 1,082
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fenelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,037
Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity
Oades, R. D., & Halliday, G. M. (1987) · Brain Research Reviews · doi:10.1016/0165-0173(87)90011-7 · Cited by 1,008
Cognitive profile of patients with newly diagnosed Parkinson disease
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005) · Neurology · doi:10.1212/01.wnl.0000180516.69442.95 · Cited by 1,007 · cited 3×
“Executive dysfunction is often present in Parkinson’s disease from the point of diagnosis (Lees and Smith, 1983; Foltynie et al. , 2004 a ; Muslimovic et al. , 2005), and may even be part of a pre-motor prodromal syndrome (Goldman et al. , 2014 b ).”
The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., Brayne, C., Kolachana, B. S., Weinberger, D. R., Sawcer, S. J., et al. (2009) · Brain · doi:10.1093/brain/awp245 · Cited by 965
Self-citationEvolution of cognitive dysfunction in an incident Parkinson's disease cohort
Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2007) · Brain · doi:10.1093/brain/awm111 · Cited by 934
Self-citationParasuraman, R. (1998) · Cited by 917
Cools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906
Cools, R. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.024 · Cited by 903
Cognitive deficits in Parkinson’s disease
Dubois, B., & Pillon, B. (1996) · Journal of Neurology · doi:10.1007/pl00007725 · Cited by 903
Role of locus coeruleus in attention and behavioral flexibility
Aston-Jones, G., Rajkowski, J., & Cohen, J. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00140-7 · Cited by 900
FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASE: THE CORTICAL FOCUS OF NEOSTRIATAL OUTFLOW
TAYLOR, A. E., SAINT-CYR, J. A., & LANG, A. E. (1986) · Brain · doi:10.1093/brain/109.5.845 · Cited by 882
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Nucleus basalis and thalamic control of neocortical activity in the freely moving rat
Buzsaki, G., Bickford, R., Ponomareff, G., Thal, L., Mandel, R., & Gage, F. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04007.1988 · Cited by 848
‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
The pedunculopontine nucleus and Parkinson's disease
Pahapill, P. A. (2000) · Brain · doi:10.1093/brain/123.9.1767 · Cited by 831
Posner, M. I., & Dehaene, S. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90078-7 · Cited by 825
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06891.x · Cited by 811 · cited 2×
“Although insight is initially maintained in patients with PDD, 81% will lose insight over 3 years (Fe´nelon et al. , 2000; Goetz et al. , 2006), which severely affects quality of life for both patients and caregivers (Goetz and Stebbins, 1993; Aarsland et al. , 2000).”
COGNITIVE DEFICITS IN THE EARLY STAGES OF PARKINSON'S DISEASE
LEES, A. J., & SMITH, E. (1983) · Brain · doi:10.1093/brain/106.2.257 · Cited by 790
Williams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., Scott, R., Ives, N., Rick, C., Daniels, J., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70093-4 · Cited by 733
Scatton, B., Javoy-Agid, F., Rouquier, L., Dubois, B., & Agid, Y. (1983) · Brain Research · doi:10.1016/0006-8993(83)90993-9 · Cited by 726
The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study
Foltynie, T., Brayne, C. E. G., Robbins, T. W., & Barker, R. A. (2004) · Brain · doi:10.1093/brain/awh067 · Cited by 688
Self-citationDementia associated with Parkinson's disease
Emre, M. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00351-x · Cited by 685
The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort
Williams-Gray, C. H., Mason, S. L., Evans, J. R., Foltynie, T., Brayne, C., Robbins, T. W., & Barker, R. A. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305277 · Cited by 681
Self-citationSarter, M., Hasselmo, M. E., Bruno, J. P., & Givens, B. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.08.006 · Cited by 667
Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M. O., Krause, M., Tronnier, V., Kloss, M., Schnitzler, A., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70114-5 · Cited by 651
Burton, E. J. (2004) · Brain · doi:10.1093/brain/awh088 · Cited by 647
Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe
Harding, A. J., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 609
Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease
Hurtig, H. I., Trojanowski, J. Q., Galvin, J., Ewbank, D., Schmidt, M. L., Lee, V. M. Y., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., et al. (2000) · Neurology · doi:10.1212/wnl.54.10.1916 · Cited by 601
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Compta, Y., Parkkinen, L., O'Sullivan, S. S., Vandrovcova, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 583
The epidemiology of dementia associated with Parkinson disease
Aarsland, D., & Kurz, M. W. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.034 · Cited by 578
Metherate, R., Cox, C., & Ashe, J. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04701.1992 · Cited by 574
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Cognitive Impairment in Parkinson’s Disease: The Dual Syndrome Hypothesis
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2013) · Neurodegenerative Diseases · doi:10.1159/000341998 · Cited by 573
Perry, E. K., Curtis, M., Dick, D. J., Candy, J. M., Atack, J. R., Bloxham, C. A., Blessed, G., Fairbairn, A., Tomlinson, B. E., & Perry, R. H. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.5.413 · Cited by 571
Huerta, P. T., & Lisman, J. E. (1993) · Nature · doi:10.1038/364723a0 · Cited by 570
Basal forebrain activation enhances cortical coding of natural scenes
Goard, M., & Dan, Y. (2009) · Nature Neuroscience · doi:10.1038/nn.2402 · Cited by 556
More attention must be paid: The neurobiology of attentional effort
Sarter, M., Gehring, W. J., & Kozak, R. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.002 · Cited by 552
Bohnen, N. I., Kaufer, D. I., Ivanco, L. S., Lopresti, B., Koeppe, R. A., Davis, J. G., Mathis, C. A., Moore, R. Y., & DeKosky, S. T. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1745 · Cited by 551
Basal forebrain neurons in the dementia of Parkinson disease
Whitehouse, P. J., Hedreen, J. C., White, C. L., & Price, D. L. (1983) · Annals of Neurology · doi:10.1002/ana.410130304 · Cited by 534
Lewis, S. J. G., Dove, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06351.2003 · Cited by 532
He, Y., Wang, L., Zang, Y., Tian, L., Zhang, X., Li, K., & Jiang, T. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.11.042 · Cited by 530
Fast modulation of visual perception by basal forebrain cholinergic neurons
Pinto, L., Goard, M. J., Estandian, D., Xu, M., Kwan, A. C., Lee, S.-H., Harrison, T. C., Feng, G., & Dan, Y. (2013) · Nature Neuroscience · doi:10.1038/nn.3552 · Cited by 529
Hasselmo, M. E., & McGaughy, J. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45015-2 · Cited by 525
Neuropathologic substrates of Parkinson disease dementia
Irwin, D. J., White, M. T., Toledo, J. B., Xie, S. X., Robinson, J. L., Van Deerlin, V., Lee, V. M. ‐., Leverenz, J. B., Montine, T. J., Duda, J. E., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23659 · Cited by 518
Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry
Owen, A. M. (2004) · The Neuroscientist · doi:10.1177/1073858404266776 · Cited by 496
Swainson, R., Rogers, R. D., Sahakian, B. J., Summers, B. A., Polkey, C. E., & Robbins, T. W. (2000) · Neuropsychologia · doi:10.1016/s0028-3932(99)00103-7 · Cited by 494
Executive dysfunction in Parkinson's disease: A review
Dirnberger, G., & Jahanshahi, M. (2013) · Journal of Neuropsychology · doi:10.1111/jnp.12028 · Cited by 486
Self-citationVoytko, M., Olton, D., Richardson, R., Gorman, L., Tobin, Jr., & Price, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00167.1994 · Cited by 483
Induction of a physiological memory in the cerebral cortex by stimulation of the nucleus basalis.
Bakin, J. S., & Weinberger, N. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11219 · Cited by 478
Reassessment of the structural basis of the ascending arousal system
Fuller, P., Sherman, D., Pedersen, N. P., Saper, C. B., & Lu, J. (2011) · Journal of Comparative Neurology · doi:10.1002/cne.22559 · Cited by 465
Aarsland, D., Ballard, C., Walker, Z., Bostrom, F., Alves, G., Kossakowski, K., Leroi, I., Pozo-Rodriguez, F., Minthon, L., & Londos, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70146-2 · Cited by 459
Risk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 455
Dementia and survival in Parkinson disease: A 12-year population study
Buter, T. C., van den Hout, A., Matthews, F. E., Larsen, J. P., Brayne, C., & Aarsland, D. (2008) · Neurology · doi:10.1212/01.wnl.0000306632.43729.24 · Cited by 451
Cholinergic Basal Forebrain Neurons Burst with Theta during Waking and Paradoxical Sleep
Lee, M. G., Hassani, O. K., Alonso, A., & Jones, B. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0178-05.2005 · Cited by 439
Burn, D. J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.081711 · Cited by 436
Emre, M., Tsolaki, M., Bonuccelli, U., Destée, A., Tolosa, E., Kutzelnigg, A., Ceballos-Baumann, A., Zdravkovic, S., Bladström, A., & Jones, R. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70194-0 · Cited by 436
Changes in motor subtype and risk for incident dementia in Parkinson's disease
Alves, G., Larsen, J. P., Emre, M., Wentzel‐Larsen, T., & Aarsland, D. (2006) · Movement Disorders · doi:10.1002/mds.20897 · Cited by 434
Mesocortical dopamine modulation of executive functions: beyond working memory
Floresco, S. B., & Magyar, O. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0404-5 · Cited by 426
Some cognitive effects of frontal-lobe lesions in man
Milner, B. A. (1982) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1982.0083 · Cited by 426
Kuhl, D. E., Minoshima, S., Fessler, J. A., Ficaro, E. P., Wieland, D. M., Koeppe, R. A., Frey, K. A., & Foster, N. L. (1996) · Annals of Neurology · doi:10.1002/ana.410400309 · Cited by 426
Zgaljardic, D. J., Borod, J. C., Foldi, N. S., & Mattis, P. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00001 · Cited by 421
Verbal fluency deficits in Parkinson's disease: A meta-analysis
HENRY, J. D., & CRAWFORD, J. R. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704104141 · Cited by 421
Rolinski, M., Fox, C., Maidment, I., & McShane, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006504.pub2 · Cited by 418
Is the mesocortical dopaminergic system involved in Parkinson disease?
Javoy-Agid, F., & Agid, Y. (1980) · Neurology · doi:10.1212/wnl.30.12.1326 · Cited by 413
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
Kempster, P. A., O'Sullivan, S. S., Holton, J. L., Revesz, T., & Lees, A. J. (2010) · Brain · doi:10.1093/brain/awq059 · Cited by 410
Parkinson Disease Neuropathology: Later-Developing Dementia and Loss of the Levodopa Response
Apaydin, H., Ahlskog, J. E., Parisi, J. E., Boeve, B. F., & Dickson, D. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.102 · Cited by 399
Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways
Hilker, R., Thomas, A. V., Klein, J. C., Weisenbach, S., Kalbe, E., Burghaus, L., Jacobs, A. H., Herholz, K., & Heiss, W. D. (2005) · Neurology · doi:10.1212/01.wnl.0000191154.78131.f6 · Cited by 384
Bonanni, L., Thomas, A., Tiraboschi, P., Perfetti, B., Varanese, S., & Onofrj, M. (2008) · Brain · doi:10.1093/brain/awm322 · Cited by 379
The neurobiological basis of cognitive impairment in Parkinson's disease
Halliday, G. M., Leverenz, J. B., Schneider, J. S., & Adler, C. H. (2014) · Movement Disorders · doi:10.1002/mds.25857 · Cited by 366
Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET
Shimada, H., Hirano, S., Shinotoh, H., Aotsuka, A., Sato, K., Tanaka, N., Ota, T., Asahina, M., Fukushi, K., Kuwabara, S., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab2b58 · Cited by 366
Bohnen, N. I., Kaufer, D. I., Hendrickson, R., Ivanco, L. S., Lopresti, B. J., Constantine, G. M., Mathis, C. A., Davis, J. G., Moore, R. Y., & DeKosky, S. T. (2006) · Journal of Neurology · doi:10.1007/s00415-005-0971-0 · Cited by 364
Anatomy of the Prefrontal Cortex
Fuster, J. M. (2008) · The Prefrontal Cortex · doi:10.1016/b978-0-12-373644-4.00002-5 · Cited by 364
Walker, M. P., Ayre, G. A., Cummings, J. L., Wesnes, K., McKeith, I. G., O'Brien, J. T., & Ballard, C. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.3.252 · Cited by 362
Mattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 361
Metabolic brain networks associated with cognitive function in Parkinson's disease
Huang, C., Mattis, P., Tang, C., Perrine, K., Carbon, M., & Eidelberg, D. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.003 · Cited by 361
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo
Klein, J. C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., Baudrexel, S., Diederich, N. J., Heiss, W. D., & Hilker, R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d55f61 · Cited by 356
Parkkinen, L., Pirttilä, T., & Alafuzoff, I. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0346-6 · Cited by 354
Parkinson's disease is associated with hippocampal atrophy
Camicioli, R., Moore, M. M., Kinney, A., Corbridge, E., Glassberg, K., & Kaye, J. A. (2003) · Movement Disorders · doi:10.1002/mds.10444 · Cited by 343
Neural Bases of Set-Shifting Deficits in Parkinson's Disease
Monchi, O., Petrides, M., Doyon, J., Postuma, R. B., Worsley, K., & Dagher, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4860-03.2004 · Cited by 341
Visual hallucinations in Parkinson's disease: a review and phenomenological survey
Barnes, J. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.6.727 · Cited by 340
Zadikoff, C., Fox, S. H., Tang‐Wai, D. F., Thomsen, T., de Bie, R. M. A., Wadia, P., Miyasaki, J., Duff‐Canning, S., Lang, A. E., & Marras, C. (2008) · Movement Disorders · doi:10.1002/mds.21837 · Cited by 339
Calabresi, P., Picconi, B., Parnetti, L., & Di Filippo, M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70600-7 · Cited by 338
Explicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases
Pillon, B., Deweer, B., Agid, Y., & Dubois, B. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540040036010 · Cited by 316
Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex
Jones, B. E. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)45011-5 · Cited by 309
Lewis, S. J. G., Slabosz, A., Robbins, T. W., Barker, R. A., & Owen, A. M. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.10.001 · Cited by 309
Postuma, R. B., Bertrand, J., Montplaisir, J., Desjardins, C., Vendette, M., Rios Romenets, S., Panisset, M., & Gagnon, J. (2012) · Movement Disorders · doi:10.1002/mds.24939 · Cited by 305
Nazem, S., Siderowf, A. D., Duda, J. E., Ten Have, T., Colcher, A., Horn, S. S., Moberg, P. J., Wilkinson, J. R., Hurtig, H. I., Stern, M. B., et al. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02096.x · Cited by 304
Hall, H., Reyes, S., Landeck, N., Bye, C., Leanza, G., Double, K., Thompson, L., Halliday, G., & Kirik, D. (2014) · Brain · doi:10.1093/brain/awu193 · Cited by 302
Williams, D. R., & Lees, A. J. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70146-0 · Cited by 300
Attention to action in Parkinson’s disease
Rowe, J., Stephan, K. E., Friston, K., Frackowiak, R., Lees, A., & Passingham, R. (2002) · Brain · doi:10.1093/brain/awf036 · Cited by 300
Owen, A. (1998) · Brain · doi:10.1093/brain/121.5.949 · Cited by 299
Cortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 297
The association of incident dementia with mortality in PD
Levy, G., Tang, M.-X., Louis, E. D., Côté, L. J., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Neurology · doi:10.1212/01.wnl.0000036610.36834.e0 · Cited by 297
Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction
Mufson, E. J., Ginsberg, S. D., Ikonomovic, M. D., & DeKosky, S. T. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(03)00068-1 · Cited by 295
Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease.
Owen, A. M., Sahakian, B. J., Hodges, J. R., Summers, B. A., Polkey, C. E., & Robbins, T. W. (1995) · Neuropsychology · doi:10.1037//0894-4105.9.1.126 · Cited by 294
Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2005) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290
Visuospatial impairment in Parkinson's disease
Levin, B. E., Llabre, M. M., Reisman, S., Weiner, W. J., Sanchez-Ramos, J., Singer, C., & Brown, M. C. (1991) · Neurology · doi:10.1212/wnl.41.3.365 · Cited by 289
Fluctuations in attention: PD dementia vs DLB with parkinsonism
Ballard, C. G., Aarsland, D., McKeith, I., O’Brien, J., Gray, A., Cormack, F., Burn, D., Cassidy, T., Starfeldt, R., Larsen, J.-P., et al. (2002) · Neurology · doi:10.1212/01.wnl.0000036908.39696.fd · Cited by 285
Slowing of EEG in Parkinson's disease
Soikkeli, R., Partanen, J., Soininen, H., Pääkkönen, A., & Riekkinen, P. (1991) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(91)90134-p · Cited by 283
Memory and executive function impairment predict dementia in Parkinson's disease
Levy, G., Jacobs, D. M., Tang, M., Côté, L. J., Louis, E. D., Alfaro, B., Mejia, H., Stern, Y., & Marder, K. (2002) · Movement Disorders · doi:10.1002/mds.10280 · Cited by 282
Perry, E. K., & Perry, R. H. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1255 · Cited by 278
Attentional functions of cortical cholinergic inputs: What does it mean for learning and memory?
Sarter, M., Bruno, J. P., & Givens, B. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00070-4 · Cited by 278
Liu, Y., Weick, J. P., Liu, H., Krencik, R., Zhang, X., Ma, L., Zhou, G.-M., Ayala, M., & Zhang, S.-C. (2013) · Nature Biotechnology · doi:10.1038/nbt.2565 · Cited by 276
Dementia in idiopathic Parkinson's disease: A neuropathological study of 32 cases
Gaspar, P., & Gray, F. (1984) · Acta Neuropathologica · doi:10.1007/bf00695605 · Cited by 275
Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft
Hagell, P. (1999) · Brain · doi:10.1093/brain/122.6.1121 · Cited by 274
Ravina, B. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.050682 · Cited by 273
Magnocellular nuclei of the basal forebrain: substrates of sleep and arousal regulation.
Szymusiak, R. (1995) · Sleep · doi:10.1093/sleep/18.6.478 · Cited by 272
Relationship of motor symptoms to intellectual deficits in Parkinson disease
Mortimer, J. A., Pirozzolo, F. J., Hansch, E. C., & Webster, D. D. (1982) · Neurology · doi:10.1212/wnl.32.2.133 · Cited by 268
Clinical phenotype of Parkinson disease dementia
Galvin, J. E., Pollack, J., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000242630.52203.8f · Cited by 265
Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia
Kuhn, J., Hardenacke, K., Lenartz, D., Gruendler, T., Ullsperger, M., Bartsch, C., Mai, J. K., Zilles, K., Bauer, A., Matusch, A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.32 · Cited by 262
Cognitive impairment and dementia in Parkinson's disease
Pagonabarraga, J., & Kulisevsky, J. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.029 · Cited by 257
Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
Weintraub, D., Mavandadi, S., Mamikonyan, E., Siderowf, A. D., Duda, J. E., Hurtig, H. I., Colcher, A., Horn, S. S., Nazem, S., Ten Have, T. R., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd79 · Cited by 255 · cited 2×
“…re-uptake inhibitor atomoxetine may increase arousal levels, vigilance and deficits in response inhibition in Parkinson’s disease (Marsh et al. , 2009; Weintraub et al. , 2010; Kehagia et al. , 2014), in-line with the aforementioned roles of the noradrenergic network in mediating attention and…”
Norepinephrine: The redheaded stepchild of Parkinson's disease
Rommelfanger, K. S., & Weinshenker, D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.036 · Cited by 255
Bartus, R. T., Flicker, C., Dean, R. L., Pontecorvo, M., Figueiredo, J. C., & Fisher, S. K. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90139-x · Cited by 247
Grey matter atrophy in cognitively impaired Parkinson's disease
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R. J., Dalrymple-Alford, J. C., & Anderson, T. J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-300828 · Cited by 246
Cortical activity in Parkinson's disease during executive processing depends on striatal involvement
Monchi, O., Petrides, M., Mejia-Constain, B., & Strafella, A. P. (2006) · Brain · doi:10.1093/brain/awl326 · Cited by 246
Asymmetric pedunculopontine network connectivity in parkinsonian patients with freezing of gait
Fling, B. W., Cohen, R. G., Mancini, M., Nutt, J. G., Fair, D. A., & Horak, F. B. (2013) · Brain · doi:10.1093/brain/awt172 · Cited by 244
Del Tredici, K., & Braak, H. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301817 · Cited by 236
Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease
Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V., & Eidelberg, D. (2008) · Neurology · doi:10.1212/01.wnl.0000304050.05332.9c · Cited by 232
Structural Brain Changes in Parkinson Disease With Dementia: A Voxel-Based Morphometry Study
Summerfield, C., Junqué, C., Tolosa, E., Salgado-Pineda, P., Gómez-Ansón, B., Martí, M. J., Pastor, P., Ramírez-Ruíz, B., & Mercader, J. (2005) · Archives of Neurology · doi:10.1001/archneur.62.2.281 · Cited by 227
Fahn, S., Libsch, L. R., & Cutler, R. W. (1971) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(71)90178-x · Cited by 224
Kahan, J., Urner, M., Moran, R., Flandin, G., Marreiros, A., Mancini, L., White, M., Thornton, J., Yousry, T., Zrinzo, L., et al. (2014) · Brain · doi:10.1093/brain/awu027 · Cited by 216
Self-citationTam, C. W. C., Burton, E. J., McKeith, I. G., Burn, D. J., & O’Brien, J. T. (2005) · Neurology · doi:10.1212/01.wnl.0000153070.82309.d4 · Cited by 209
Parkinson Disease With Dementia: Comparing Patients With and Without Alzheimer Pathology
Sabbagh, M. N., Adler, C. H., Lahti, T. J., Connor, D. J., Vedders, L., Peterson, L. K., Caviness, J. N., Shill, H. A., Sue, L. I., Ziabreva, I., et al. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31819c5ef4 · Cited by 209
Shine, J. M., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2011) · Movement Disorders · doi:10.1002/mds.23896 · Cited by 204
Cognitive status correlates with white matter alteration in Parkinson's disease
Hattori, T., Orimo, S., Aoki, S., Ito, K., Abe, O., Amano, A., Sato, R., Sakai, K., & Mizusawa, H. (2012) · Human Brain Mapping · doi:10.1002/hbm.21245 · Cited by 201
Resting state oscillatory brain dynamics in Parkinson’s disease: An MEG study
Bosboom, J. L. W., Stoffers, D., Stam, C. J., van Dijk, B. W., Verbunt, J., Berendse, H. W., & Wolters, E. C. (2006) · Clinical Neurophysiology · doi:10.1016/j.clinph.2006.06.720 · Cited by 200
Lewy body cortical involvement may not always predict dementia in Parkinson's disease
Colosimo, C. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.852 · Cited by 200
Parasuraman, R., Warm, J. S., & See, J. E. (1998) · Cited by 197
Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus
Cash, R., Dennis, T., L'Heureux, R., Raisman, R., Javoy-Agid, F., & Scatton, B. (1987) · Neurology · doi:10.1212/wnl.37.1.42 · Cited by 196
McConnell, G. C., So, R. Q., Hilliard, J. D., Lopomo, P., & Grill, W. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2824-12.2012 · Cited by 193
Altered cortical visual processing in PD with hallucinations: An fMRI study
Stebbins, G. T., Goetz, C. G., Carrillo, M. C., Bangen, K. J., Turner, D. A., Glover, G. H., & Gabrieli, J. D. E. (2004) · Neurology · doi:10.1212/01.wnl.0000141853.27081.bd · Cited by 189
Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease
WOODS, S. P., & TRÖSTER, A. I. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703910022 · Cited by 187
Meppelink, A. M., de Jong, B. M., Renken, R., Leenders, K. L., Cornelissen, F. W., & van Laar, T. (2009) · Brain · doi:10.1093/brain/awp223 · Cited by 183
Janvin, C. C., Aarsland, D., & Larsen, J. P. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705277540 · Cited by 182
Williams-Gray, C. H., Hampshire, A., Robbins, T. W., Owen, A. M., & Barker, R. A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0774-07.2007 · Cited by 180
Prospective longitudinal assessment of hallucinations in Parkinson’s disease
Goetz, C. G., Leurgans, S., Pappert, E. J., Raman, R., & Stemer, A. B. (2001) · Neurology · doi:10.1212/wnl.57.11.2078 · Cited by 178
Marié, R. M., Barré, L., Dupuy, B., Viader, F., Defer, G., & Baron, J. C. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00928-8 · Cited by 177
Bentley, P., Husain, M., & Dolan, R. J. (2004) · Neuron · doi:10.1016/s0896-6273(04)00145-x · Cited by 176
Cholinergic modulation of cognition: Insights from human pharmacological functional neuroimaging
Bentley, P., Driver, J., & Dolan, R. J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.06.002 · Cited by 175
Christopher, L., Marras, C., Duff-Canning, S. J., Koshimori, Y., Chen, R. E., Boileau, I., Segura, B., Monchi, O., Lang, A. E., Rusjan, P., et al. (2013) · Brain · doi:10.1093/brain/awt337 · Cited by 173
Cognitive Functions in a Patient With Parkinson-Dementia Syndrome Undergoing Deep Brain Stimulation
Freund, H.-J., Kuhn, J., Lenartz, D., Mai, J. K., Schnell, T., Klosterkoetter, J., & Sturm, V. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.102 · Cited by 170
Brück, A., Portin, R., Lindell, A., Laihinen, A., Bergman, J., Haaparanta, M., Solin, O., & Rinne, J. O. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02124-3 · Cited by 168
Wright, M. J., Burns, R. J., Geffen, G. M., & Geffen, L. B. (1990) · Neuropsychologia · doi:10.1016/0028-3932(90)90097-8 · Cited by 167
Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B. A., Merkitch, D., deToledo‐Morrell, L., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awt360 · Cited by 166
Nonpharmacological enhancement of cognitive function in Parkinson's disease: A systematic review
Hindle, J. V., Petrelli, A., Clare, L., & Kalbe, E. (2013) · Movement Disorders · doi:10.1002/mds.25377 · Cited by 165
Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia
Junqué, C., Ramírez‐Ruiz, B., Tolosa, E., Summerfield, C., Martí, M., Pastor, P., Gómez‐Ansón, B., & Mercader, J. M. (2005) · Movement Disorders · doi:10.1002/mds.20371 · Cited by 165
Attentional control in Parkinson's disease is dependent on COMT val158met genotype
Williams-Gray, C. H., Hampshire, A., Barker, R. A., & Owen, A. M. (2008) · Brain · doi:10.1093/brain/awm313 · Cited by 165
Lee, J. E., Cho, K. H., Song, S. K., Kim, H. J., Lee, H. S., Sohn, Y. H., & Lee, P. H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305062 · Cited by 165
The spectrum of cognitive impairment in Lewy body diseases
Goldman, J. G., Williams‐Gray, C. H., Barker, R. A., Duda, J. E., & Galvin, J. E. (2014) · Movement Disorders · doi:10.1002/mds.25866 · Cited by 162
González-Redondo, R., García-García, D., Clavero, P., Gasca-Salas, C., García-Eulate, R., Zubieta, J. L., Arbizu, J., Obeso, J. A., & Rodríguez-Oroz, M. C. (2014) · Brain · doi:10.1093/brain/awu159 · Cited by 162
The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?
Gratwicke, J., Kahan, J., Zrinzo, L. U., Hariz, M. I., Limousin, P. D., Foltynie, T., & Jahanshahi, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.003 · Cited by 162
Self-citationCognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?
Voytko, M. L. (1996) · Behavioural Brain Research · doi:10.1016/0166-4328(95)00143-3 · Cited by 162
Nombela, C., Rowe, J. B., Winder‐Rhodes, S., Hampshire, A., Owen, A. M., Breen, D. P., Duncan, G. W., Khoo, T. K., Yarnall, A. J., Firbank, M., et al. (2014) · Brain · doi:10.1093/brain/awu201 · Cited by 162
The Malignant Course of “Benign Hallucinations” in Parkinson Disease
Goetz, C. G., Fan, W., Leurgans, S., Bernard, B., & Stebbins, G. T. (2006) · Archives of Neurology · doi:10.1001/archneur.63.5.713 · Cited by 161
The locus ceruleus and dementia in Parkinson's disease
Zweig, R. M., Cardillo, J. E., Cohen, M., Giere, S., & Hedreen, J. C. (1993) · Neurology · doi:10.1212/wnl.43.5.986 · Cited by 161
Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease
París, A. P., Saleta, H. G., de la Cruz Crespo Maraver, M., Silvestre, E., Freixa, M. G., Torrellas, C. P., Pont, S. A., Nadal, M. F., Garcia, S. A., Bartolomé, M. V. P., et al. (2011) · Movement Disorders · doi:10.1002/mds.23688 · Cited by 160
Bronnick, K. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.093146 · Cited by 160
Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: The 15‐objects test
Pillon, B., Dubois, B., Bonnet, A.-M., Esteguy, M., Guimaraes, J., Vigouret, J.-M., Lhermitte, F., & Agid, Y. (1989) · Neurology · doi:10.1212/wnl.39.6.762 · Cited by 160
Benefits of rivastigmine on attention in dementia associated with Parkinson disease
Wesnes, K. A., McKeith, I., Edgar, C., Emre, M., & Lane, R. (2005) · Neurology · doi:10.1212/01.wnl.0000184517.69816.e9 · Cited by 159
Targeting impulsivity in Parkinson’s disease using atomoxetine
Kehagia, A. A., Housden, C. R., Regenthal, R., Barker, R. A., Müller, U., Rowe, J. B., Sahakian, B. J., & Robbins, T. W. (2014) · Brain · doi:10.1093/brain/awu117 · Cited by 159
The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status
Song, S., Lee, J. E., Park, H., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2011) · Movement Disorders · doi:10.1002/mds.23477 · Cited by 156
Rosenthal, E. W., Brennan, L., Xie, S. X., Hurtig, H. I., Milber, J. M., Weintraub, D. A., Karlawish, J. H., & Siderowf, A. D. (2010) · Movement Disorders · doi:10.1002/mds.23073 · Cited by 153
Training of executive functions in Parkinson's disease
Sammer, G., Reuter, I., Hullmann, K., Kaps, M., & Vaitl, D. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.028 · Cited by 151
Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease
Kalaitzakis, M. E., Christian, L., Moran, L. B., Graeber, M. B., Pearce, R. K. B., & Gentleman, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.007 · Cited by 150
Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia
Ibarretxe‐Bilbao, N., Ramírez‐Ruiz, B., Tolosa, E., Martí, M. J., Valldeoriola, F., Bargalló, N., & Junqué, C. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0885-8 · Cited by 149
Palliative therapy in the terminal stage of neurological disease
Voltz, R., & Borasio, G. D. (1997) · Journal of Neurology · doi:10.1007/pl00007721 · Cited by 148
Executive dysfunction in Parkinson’s disease and timing deficits
Parker, K. L., Lamichhane, D., Caetano, M. S., & Narayanan, N. S. (2013) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2013.00075 · Cited by 148
Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease
Pereira, J. B., Junqué, C., Martı́, M. J., Ramírez‐Ruiz, B., Bargalló, N., & TOLOSA, E. S. (2009) · Movement Disorders · doi:10.1002/mds.22560 · Cited by 147
Characterizing mild cognitive impairment in Parkinson's disease
Dalrymple‐Alford, J. C., Livingston, L., MacAskill, M. R., Graham, C., Melzer, T. R., Porter, R., Watts, R., & Anderson, T. (2011) · Movement Disorders · doi:10.1002/mds.23592 · Cited by 146
Shine, J. M., Halliday, G. M., Gilat, M., Matar, E., Bolitho, S., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2013) · Human Brain Mapping · doi:10.1002/hbm.22321 · Cited by 144
Marsh, L., Biglan, K., Gerstenhaber, M., & Williams, J. R. (2008) · Movement Disorders · doi:10.1002/mds.22307 · Cited by 144
Cited by
The future of stem cell therapies for Parkinson disease
Parmar, M., Grealish, S., & Henchcliffe, C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0257-7 · Cited by 306
Neuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
Bohnen, N. I., Yarnall, A. J., Weil, R. S., Moro, E., Moehle, M. S., Borghammer, P., Bedard, M.-A., & Albin, R. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00377-x · Cited by 293
Werry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
Zhang, D., Li, S., Hou, L., Jing, L., Ruan, Z., Peng, B., Zhang, X., Hong, J.-S., Zhao, J., & Wang, Q. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02065-z · Cited by 187
Metadata
- Authors
- Gratwicke, J., Jahanshahi, M., & Foltynie, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-16
- Volume
- 138
- Issue
- 6
- Pages
- 1454-1476
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2129697505
- Cited by
- 435
- References
- 287
- FWCI
- 22.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.